The 5 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 18.00, with a high estimate of 22.00 and a low estimate of 15.50. The median estimate represents a +4.29% increase from the last price of 17.26.
The current consensus among 5 polled investment analysts is to Buy stock in Catalyst Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.20
Reporting Date Mar 15
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.